IndustryPayments
Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

UZOMA OSUCHUKWU

Allopathic & Osteopathic Physicians Psychiatry & Neurology Child & Adolescent Psychiatry

NPI
1063760411
CMS profile
4225164
Location
NORTH LAS VEGAS, NV

General Payments · PY2018–2024

$3,720.61

  • Reported across 155 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$1,164.86

49 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

Related groups: Child & Adolescent Psychiatry NV All categories

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $1,137.59 48
Education $27.27 1

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
ITI, Inc. $396.11 16
Janssen Pharmaceuticals, Inc $203.29 8
Vanda Pharmaceuticals Inc. $115.14 3
Corium, Inc. $98.42 5
ABBVIE INC. $79.51 4
E.R. Squibb & Sons, L.L.C. $67.73 3
Bausch Health US, LLC $44.34 2
Alkermes, Inc. $43.88 2
Supernus Pharmaceuticals, Inc. $28.46 2
Tempus AI, Inc $26.34 1
IRONSHORE PHARMACEUTICALS INC. $22.08 1
Otsuka America Pharmaceutical, Inc. $19.83 1
Neurocrine BioSciences, Inc. $19.73 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $200.37 5
PY2019 $346.05 15
PY2020 $99.81 5
PY2021 $553.34 22
PY2022 $673.17 31
PY2023 $683.01 28
PY2024 $1,164.86 49

Payment records · PY2024 (49)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $21.39 01/31/2024 Food and Beverage Undisputed 01/23/2026 1105162087 CMS
ABBVIE INC. $19.75 04/24/2024 Food and Beverage Undisputed 01/23/2026 1105162089 CMS
ABBVIE INC. $17.79 08/07/2024 Food and Beverage Undisputed 01/23/2026 1105162091 CMS
ABBVIE INC. $20.58 10/08/2024 Food and Beverage Undisputed 01/23/2026 1105162093 CMS
Alkermes, Inc. $21.40 01/30/2024 Food and Beverage Undisputed 01/23/2026 1120567869 CMS
Alkermes, Inc. $22.48 05/31/2024 Food and Beverage Undisputed 01/23/2026 1120567871 CMS
Bausch Health US, LLC $20.39 08/14/2024 Food and Beverage Undisputed 01/23/2026 1148025550 CMS
Bausch Health US, LLC $23.95 10/15/2024 Food and Beverage Undisputed 01/23/2026 1148025552 CMS
Corium, LLC $21.06 01/10/2024 Food and Beverage Undisputed 01/23/2026 1100094133 CMS
Corium, LLC $9.17 02/21/2024 Food and Beverage Undisputed 01/23/2026 1100124448 CMS
Corium, LLC $22.06 03/18/2024 Food and Beverage Undisputed 01/23/2026 1100091238 CMS
Corium, LLC $31.02 08/28/2024 Food and Beverage Undisputed 01/23/2026 1100202104 CMS
Corium, LLC $15.11 10/10/2024 Food and Beverage Undisputed 01/23/2026 1100164613 CMS
E.R. Squibb & Sons, L.L.C. $27.27 11/04/2024 Education Undisputed 01/23/2026 1101663045 CMS
E.R. Squibb & Sons, L.L.C. $16.59 11/04/2024 Food and Beverage Undisputed 01/23/2026 1101663049 CMS
E.R. Squibb & Sons, L.L.C. $23.87 11/26/2024 Food and Beverage Undisputed 01/23/2026 1101663060 CMS
IRONSHORE PHARMACEUTICALS INC. $22.08 03/16/2024 Food and Beverage Undisputed 01/23/2026 1146315211 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $23.65 01/18/2024 Food and Beverage Undisputed 01/23/2026 1143290823 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.38 02/21/2024 Food and Beverage Undisputed 01/23/2026 1143290827 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.34 03/13/2024 Food and Beverage Undisputed 01/23/2026 1143290831 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.61 03/22/2024 Food and Beverage Undisputed 01/23/2026 1143290834 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $7.38 05/07/2024 Food and Beverage Undisputed 01/23/2026 1143290838 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $15.86 05/22/2024 Food and Beverage Undisputed 01/23/2026 1143290842 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.91 05/30/2024 Food and Beverage Undisputed 01/23/2026 1143290846 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $6.32 06/24/2024 Food and Beverage Undisputed 01/23/2026 1143290849 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $19.56 07/04/2024 Food and Beverage Undisputed 01/23/2026 1143290853 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.26 07/24/2024 Food and Beverage Undisputed 01/23/2026 1143290857 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $20.98 08/19/2024 Food and Beverage Undisputed 01/23/2026 1143290860 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.32 09/05/2024 Food and Beverage Undisputed 01/23/2026 1143290864 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $10.49 10/03/2024 Food and Beverage Undisputed 01/23/2026 1143290868 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $22.02 10/15/2024 Food and Beverage Undisputed 01/23/2026 1143290871 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $149.01 10/17/2024 Food and Beverage Undisputed 01/23/2026 1143290875 CMS
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.02 11/18/2024 Food and Beverage Undisputed 01/23/2026 1143290879 CMS
Janssen Pharmaceuticals, Inc $32.64 01/06/2024 Food and Beverage Undisputed 01/23/2026 1078102374 CMS
Janssen Pharmaceuticals, Inc $22.10 03/12/2024 Food and Beverage Undisputed 01/23/2026 1078102364 CMS
Janssen Pharmaceuticals, Inc $29.49 03/23/2024 Food and Beverage Undisputed 01/23/2026 1078102362 CMS
Janssen Pharmaceuticals, Inc $28.44 05/27/2024 Food and Beverage Undisputed 01/23/2026 1078102370 CMS
Janssen Pharmaceuticals, Inc $22.02 06/18/2024 Food and Beverage Undisputed 01/23/2026 1078102360 CMS
Janssen Pharmaceuticals, Inc $32.74 08/09/2024 Food and Beverage Undisputed 01/23/2026 1078102372 CMS
Janssen Pharmaceuticals, Inc $15.18 09/10/2024 Food and Beverage Undisputed 01/23/2026 1078102376 CMS
Janssen Pharmaceuticals, Inc $20.68 10/22/2024 Food and Beverage Undisputed 01/23/2026 1078102366 CMS
Neurocrine Biosciences, Inc. $19.73 11/12/2024 Food and Beverage Undisputed 01/23/2026 1150859915 CMS
Otsuka America Pharmaceutical, Inc. $19.83 12/04/2024 Food and Beverage Undisputed 01/23/2026 1118954902 CMS
Supernus Pharmaceuticals, Inc. $14.69 02/19/2024 Food and Beverage Undisputed 01/23/2026 1147842471 CMS
Supernus Pharmaceuticals, Inc. $13.77 06/02/2024 Food and Beverage Undisputed 01/23/2026 1147781722 CMS
Tempus AI, Inc $26.34 12/03/2024 Food and Beverage Undisputed 01/23/2026 1150171295 CMS
Vanda Pharmaceuticals Inc. $38.94 06/14/2024 Food and Beverage Undisputed 01/23/2026 1133915023 CMS
Vanda Pharmaceuticals Inc. $37.65 07/12/2024 Food and Beverage Undisputed 01/23/2026 1133915025 CMS
Vanda Pharmaceuticals Inc. $38.55 09/17/2024 Food and Beverage Undisputed 01/23/2026 1133915027 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.